Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Koninklijke Philips (PHG) Cash & Equivalents (2016 - 2025)

Koninklijke Philips has reported Cash & Equivalents over the past 11 years, most recently at $3.3 billion for Q4 2025.

  • Quarterly results put Cash & Equivalents at $3.3 billion for Q4 2025, up 26.76% from a year ago — trailing twelve months through Dec 2025 was $3.3 billion (up 26.76% YoY), and the annual figure for FY2025 was $3.2 billion, up 23.03%.
  • Cash & Equivalents for Q4 2025 was $3.3 billion at Koninklijke Philips, up from $2.6 billion in the prior quarter.
  • Over the last five years, Cash & Equivalents for PHG hit a ceiling of $3.3 billion in Q4 2025 and a floor of $1.2 billion in Q4 2022.
  • Median Cash & Equivalents over the past 5 years was $2.6 billion (2024), compared with a mean of $2.3 billion.
  • Biggest five-year swings in Cash & Equivalents: plummeted 54.61% in 2022 and later surged 68.18% in 2023.
  • Koninklijke Philips' Cash & Equivalents stood at $2.6 billion in 2021, then plummeted by 54.61% to $1.2 billion in 2022, then surged by 68.18% to $2.0 billion in 2023, then rose by 27.59% to $2.6 billion in 2024, then increased by 26.76% to $3.3 billion in 2025.
  • The last three reported values for Cash & Equivalents were $3.3 billion (Q4 2025), $2.6 billion (Q4 2024), and $2.0 billion (Q4 2023) per Business Quant data.